Nektar Therapeutics (NASDAQ:NKTR) Stock Price Expected to Rise, HC Wainwright Analyst Says
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) had its price target boosted by equities researchers at HC Wainwright to $120.00 in a research note issued on Tuesday, Marketbeat reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective indicates a potential upside of 312.09% from the stock’s previous […]
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) had its price target boosted by equities researchers at HC Wainwright to $120.00 in a research note issued on Tuesday, Marketbeat reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective indicates a potential upside of 312.09% from the stock’s previous […]
